Form D · Other
ZIPLINE MEDICAL INC
Campbell, CA · CIK 0001408578
Offering snapshot reported Jan 11, 2016 · SEC filing
- Reported sold
- $16.4M Offering amount: $26.9M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 23, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2016 | Initial | $16,384,362 | No comparison | 28 | SEC filing |
| May 17, 2011 | Initial | $880,040 | No comparison | 4 | SEC filing |
| Dec 17, 2009 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jul 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254835
Source: Form D, filed Jan 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amir Belson | Director |
| Patrick Berbon | Director |
| Ted Driscoll | Director |
| Balaji Muralidhar | Director |
| Stephen Reeders | Director |
| Robert Siegel | Director |
| John Tighe | Director, Executive |
| Allan Wolfe | Director |
Issuer details
Industry: Other (See others in industry)
Address:
747 Camden Avenue Suite A
Campbell, CA, 95008
Campbell, CA, 95008